Home Women's Health Policy Topics

Women's Health Policy

ABORTION IN THE U.S.

KFF infographic explaining who regulates mifepristone, showing four entities and their roles: the U.S. Food and Drug Administration approves and regulates medications for safety and effectiveness; state legislatures pass laws that can restrict or protect access; courts rule on legal cases affecting regulation; and Congress can pass federal legislation influencing regulation.

Louisiana v. FDA: Access to Mifepristone Back at the Supreme Court

Louisiana sued the FDA in October 2025, claiming the FDA’s 2023 regulatory change eliminating the requirement that mifepristone be dispensed in-person—allowing it to be mailed or dispensed at retail pharmacies—harm the state's ability to enforce its abortion ban. This brief reviews the Louisiana v. FDA case and provides an overview of the other pending litigation involving mifepristone, as well as the mounting tension between states seeking to protect abortion and those banning the provision of abortion.

CONTRACEPTIve care IN THE U.S.

An Update on Medicaid, Title X and Planned Parenthood

This brief provides an update on Planned Parenthood clinic closures and participation in the Title X program amid substantial policy changes resulting in funding reductions. These changes include the One Big Beautiful Bill Act and the withholding of federal Title X funding to Planned Parenthood clinics.

SELECTED RESOURCES

Over-the-Counter Oral Contraceptive Pills

In July 2023, the FDA approved Opill, the first daily oral contraceptive pill to become available over the counter (OTC) without a doctor’s prescription. This issue brief provides an overview of OTC oral contraceptives and laws and policies related to insurance coverage.

featured

A promotional image for the the KFF Health Policy 101 Issues in Women’s Health chapter

Health Policy Issues in Women’s Health

Examine the core health coverage and access issues —shaped by federal and state policies—that affect women’s health today, including health coverage and costs, reproductive health services, maternal health, mental health, and intimate partner violence.

State Profiles for Women’s Health

Explore the latest national and state-specific data and policies on women’s health. Topics include health status, insurance and Medicaid coverage, use of preventive services, sexual health, maternal and infant health, and abortion policies. Many indicators provide state-level information for women of different racial and ethnic groups.

The essentials

  • Women’s Health Insurance Coverage

    This factsheet reviews major sources of coverage for women residing in the U.S., discusses the ACA's impact on coverage, and the coverage challenges that many women continue to face.

  • Medicaid Coverage for Women

    This data note presents key data points describing the current state of the Medicaid program as it affects women, including eligibility, reproductive health, chronic conditions, and more.

  • Dobbs: What are the Implications for Racial Disparities?

    This analysis examines the implications of the Dobbs decision and state restrictions on abortion coverage for racial disparities in access to care and health outcomes.

  • State Health Facts: Women's Health Indicators

    Information on women’s health status, utilization of services, health insurance coverage, family planning and childbirth, and abortion statistics and policies.

  • Key Facts on Abortion in the United States

    This report answers some key questions about abortion in the United States and presents data collected before the overturn of Roe v. Wade.

Latest News

More KFF Health News

Subscribe to KFF Emails

Choose which emails are best for you.
Sign up here

View the Latest: Women's Health Policy

Filter

List Grid

861 - 870 of 872 Results

  • One Year Since Dobbs: The Landscape of Abortion Policies Across the US  

    News Release

    There has been intense focus on abortion policies across the United States since the Supreme Court’s decision in Dobbs v. Jackson Women’s Health Organization on June 24, 2022. That decision overturned Roe v. Wade, eliminating federal constitutional protections for abortion and putting the decision to restrict or protect abortion with the states.  Now, nearly one year later, what is the status of federal and state developments? Where is abortion banned? Where is litigation pending? And…

  • The Impact of Medicaid and Title X on Planned Parenthood

    Issue Brief

    This KFF analysis demonstrates the impact the exclusion of Planned Parenthood from Medicaid and the Title X funding freeze may have on low-income and uninsured individuals who get their family planning care at Planned Parenthood.

  • Want to Learn About Women’s Health in your State? Check out KFF’s Updated Interactive Dashboard

    News Release

    KFF recently updated its interactive dashboard with national and state data on women’s health, as well as information about various policies that affect women’s health. The dashboard provides instant access the most up-to-date state level indicators of women’s health in the U.S. Many of the indicators also provide national and state-level information for women of different racial and ethnic groups. Dashboard topics include: Abortion availability, coverage, and use by race/ethnicity. Maternal and infant mortality, preterm…

  • Since Dobbs, Few Large Firms Have Changed Their Plan’s Abortion Coverage Policy

    News Release

    According to an analysis of responses to KFF’s Employer Health Benefits Survey in 2023, relatively few (8%) large firms (with 200 or more workers) offering health benefits report reducing or expanding coverage for abortion since the U.S. Supreme Court overturned Roe v. Wade with the Dobbs v. Jackson ruling. Since Dobbs, 3% of these large firms reduced or eliminated coverage for abortion where it is legal. Meanwhile, 12% of large firms whose largest plan covers…

  • 3 Charts: The Cost and Coverage of Opill—the First FDA-approved Over-the-Counter Daily Oral Contraceptive Pill in the United States 

    News Release

    The first FDA-approved over-the-counter daily oral contraceptive pill in the United States— Perrigo’s Opill— is now available for pre-order at major online retailers and will soon be available in stores. Although the new over-the-counter pill could broaden access to contraceptive options in the United States, KFF research suggests consumers are likely to face some hurdles if they seek to have their plan cover the costs. For example, while federal policy requires most private health insurance…

  • 1 in 8 Voters Say Abortion Is Most Important to Their Vote: They Lean Democratic, Support Biden, and Want Abortion to Be Legal

    News Release

    About 1 in 8 voters (12%) now say that abortion is the most important issue for their vote in the 2024 elections, highlighting how the issue could motivate groups of voters who largely say abortion should be legal in all or most cases, a new KFF Health Tracking Poll finds. The issue resonates with certain key groups of women voters. More than 1 in 4 Black women voters (28%), and about a fifth of Democratic…

  • KFF Examines the Hyde Amendment and its Impact in States Without Abortion Bans

    News Release

    KFF takes a new look at the continued impact of the Hyde Amendment, the federal ban on payment for abortion services, in the wake of the Supreme Court’s Dobbs decision. At a moment when all eyes are on states that have banned abortion, the Hyde Amendment remains a barrier to abortion care for people with low incomes in states where abortion is legal but the state restricts Medicaid coverage to the narrow exceptions allowed under…

  • One in Five Women of Reproductive Age in States with Abortion Bans Say They or Someone They Know Has Had Difficulty Accessing an Abortion Since Dobbs

    News Release

    According to new KFF polling, in states with abortion bans, one in five (21%) women of reproductive age (18 to 49) and one in seven (14%) of all women say either they or someone they know has had difficulty accessing an abortion since the Supreme Court overturned Roe v. Wade. The survey finds that among all women, including in states where abortion remains broadly legal or limited by gestational period, 8% say they or someone…

  • An Update on Medicaid, Title X and Planned Parenthood

    Issue Brief

    This brief provides an update on Planned Parenthood closures and participation in the Title X program in the midst of substantial policy changes leading to decreased funding for Planned Parenthood including the One Big Beautiful Bill Act and the withholding of federal Title X funding to Planned Parenthood clinics.

  • Women’s Health Insurance Coverage

    Fact Sheet

    This fact sheet reviews major sources of coverage for women residing in the U.S. in 2024, discusses the impact of the ACA on women’s coverage, and the coverage challenges that many women continue to face.